Cerecor (CERC) News Today → Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (From Banyan Hill Publishing) (Ad) Free CERC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsInsider TradesSocial MediaStock AnalysisCompetitorsInsider TradesSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative December 19, 2023 | benzinga.comAytu BioPharma Stock (NASDAQ:AYTU) Insider TradesAugust 24, 2023 | uk.finance.yahoo.commTOR Inhibitors Global Market Report 2023May 11, 2023 | finance.yahoo.comDelveInsight Highlights Major Advances, Transformative Therapies, and 80+ Leading Players Wheeling the Crohn's Disease Pipeline LandscapeSeptember 28, 2022 | finance.yahoo.comEdited Transcript of AYTU.OQ earnings conference call or presentation 27-Sep-22 8:30pm GMT - Yahoo FinanceSeptember 28, 2022 | seekingalpha.comAytu BioPharma, Inc. (AYTU) CEO Josh Disbrow on Q4 2022 Results - Earnings Call Transcript - Seeking AlphaAugust 31, 2022 | marketwatch.comDiGeorge Syndrome Drug Market In-Depth Analysis Research Report 2029August 24, 2022 | streetinsider.comValenzaBio Appoints Industry Veteran Peter Greenleaf to its Board of Directors - StreetInsider.comAugust 24, 2022 | businesswire.comValenzaBio Appoints Industry Veteran Peter Greenleaf to its Board of Directors - Business WireAugust 11, 2022 | globenewswire.comCelldex Reports Second Quarter 2022 Financial Results and Provides Corporate Update - GlobeNewswireAugust 9, 2022 | streetinsider.comCelldex Reports Second Quarter 2022 Financial Results and Provides Corporate Update - StreetInsider.comAugust 8, 2022 | marketscreener.comCelldex Therapeutics : Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Form 8-K - Marketscreener.comJuly 24, 2022 | seekingalpha.comAvalo Therapeutics, Inc. (AVTX) Stock Price Today, Quote & News - Seeking AlphaJuly 15, 2022 | bizjournals.comPhiladelphia biotech news: Updates from CHOP, Helius Medical, GSK and more - Philadelphia Business Journal - The Business JournalsMay 3, 2022 | prnewswire.comThe Axial Spondyloarthritis Market is Predicted to Grow with a CAGR of 4.7% by 2032, Analyzes DelveInsight - PR NewswireMay 1, 2022 | marketwatch.comDiGeorge Syndrome Drug Market Size, Share, Industry Growth & Forecast By 2029April 8, 2022 | marketscreener.comAACR Poster Presentation: CFT7455 Phase 1/2 Cohort A - Marketscreener.comMarch 28, 2022 | benzinga.comDiGeorge Syndrome Drug Market High Demand, Size, Share, Processing Industry, And Forecast By 2029 - Benzi - BenzingaNovember 10, 2021 | businesswire.comModel N Announces Fourth Quarter and Fiscal Year 2021 Financial Results - Business WireNovember 10, 2021 | nasdaq.comModel N (MODN) Q4 Earnings & Revenues Top Estimates, Up Y/Y - NasdaqNovember 9, 2021 | finance.yahoo.comModel N Announces Fourth Quarter and Fiscal Year 2021 Financial Results - Yahoo FinanceNovember 9, 2021 | finance.yahoo.comAvalo Reports Third Quarter 2021 Financial Results and Provides Business Updates - Yahoo FinanceNovember 9, 2021 | stockhouse.comModel N Announces Fourth Quarter and Fiscal Year 2021 Financial Results - StockhouseOctober 7, 2021 | finance.yahoo.comHorizon Technology Finance Provides Third Quarter 2021 Portfolio Update - Yahoo FinanceAugust 27, 2021 | bizjournals.comInovio's experimental Covid-19 vaccine takes another step, plus other life sciences news - Philadelphia Business Journal - Philadelphia Business JournalAugust 27, 2021 | marketscreener.comCERECOR : Avalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc (Form 8-K) - Marketscreener.comAugust 27, 2021 | yahoo.comAvalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc. - Yahoo FinanceAugust 26, 2021 | globenewswire.comAvalo Therapeutics, Inc. Announces Corporate Name Change - GlobeNewswireAugust 26, 2021 | seekingalpha.comCerecor changes name to Avalo Therapeutics with new Nasdaq ticker - Seeking AlphaAugust 26, 2021 | finance.yahoo.comAvalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc.August 2, 2021 | finance.yahoo.comCerecor Reports Second Quarter 2021 Financial Results and Provides Business Updates - Yahoo FinanceAugust 2, 2021 | globenewswire.comCerecor Reports Second Quarter 2021 Financial Results and - GlobeNewswireAugust 2, 2021 | finance.yahoo.comCerecor Reports Second Quarter 2021 Financial Results and Provides Business UpdatesAugust 2, 2021 | globenewswire.comCerecor Announces Drawdown of $10 Million Tranche under its - GlobeNewswireJuly 28, 2021 | markets.businessinsider.com44 Stocks Moving In Tuesday's Mid-Day Session - Markets InsiderJuly 27, 2021 | globenewswire.comCerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn's Disease - GlobeNewswireJuly 27, 2021 | streetinsider.comAfter-Hours Stock Movers 07/26: (CERC) (UHS) (FFIV) Higher; (BTBT) (MINM) (TDUP) Lower (more...) - StreetInsider.comJuly 27, 2021 | finance.yahoo.comCerecor's Crohn's Disease Candidate Shows Encouraging Response In Pretreated PatientsJuly 26, 2021 | benzinga.comCerecor Announced Initial Phase 1b Results For CERC-002 In Moderate To Severe Crohn's Disease Patients - BenzingaJuly 26, 2021 | marketscreener.comCERECOR INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K) - marketscreener.comJuly 26, 2021 | finance.yahoo.comCerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn's Disease Patients - Yahoo Finance Get Cerecor News Delivered to You Automatically Sign up to receive the latest news and ratings for CERC and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide CERC Media Mentions By Week CERC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CERC News Sentiment▼0.160.55▲Average Medical News Sentiment CERC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CERC Articles This Week▼00▲CERC Articles Average Week Get Cerecor News Delivered to You Automatically Sign up to receive the latest news and ratings for CERC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ligand Pharmaceuticals News Gemini Therapeutics News Ironwood Pharmaceuticals News Gyre Therapeutics News Prothena News Belite Bio News Spyre Therapeutics News Pacira BioSciences News Mirum Pharmaceuticals News Collegium Pharmaceutical News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CERC) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldDoes this make you sick?Allegiance GoldTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerecor Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.